相关实验视频
Updated: Jul 11, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
突变p53的调节分泌会对瘤微环境中的T淋巴细胞产生负面影响
Xiang Dong1,2, Chunlu Li1,2, Chengsi Deng1,2
1The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang, Liaoning Province, China.
通过瘤衍生的外体释放的分泌突变p53,抑制CD4+T细胞和抑制糖解,促进瘤免疫逃生. 准这种分泌物可能提供一种新的癌症治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 致癌突变p53驱动瘤的进展.
- 有限的数据存在于分泌突变p53对瘤微环境和免疫逃避的影响.
研究的目的:
- 研究突变p53分泌的机制.
- 确定分泌突变p53对CD4+T细胞和瘤免疫力的影响.
- 探索针对突变的p53分泌物的治疗策略.
主要方法:
- 分析了对突变p53分泌物的外体含量.
- 研究了N-终端dieleucine动机和Ser 20酸化在分泌中的作用.
- 在体内和体外评估了CD4+T细胞功能和糖解酶活性.
- 利用基因淘汰和动机突变来抑制分泌.
主要成果:
- 突变的p53分泌取决于其N端的dieleucine动机,并被CHK2-介导的酸化抑制.
- 分泌的突变p53降低了CD4+T淋巴细胞的调节,并抑制了关键的糖解酶.
- 抑制突变p53分泌恢复CD4+T细胞功能,并抑制瘤生长.
结论:
- 瘤衍生的突变p53的外体介导分泌会通过抑制糖解抑制CD4+T细胞来降低抗瘤免疫力.
- 这种机制有助于瘤免疫逃脱.
- 向外体突变p53分泌物为癌症治疗提供了潜在的治疗途径.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
相关概念视频
Abnormal Proliferation
The Tumor Microenvironment
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy